Search results
Results from the WOW.Com Content Network
Submission of preprints is accepted by all open access journals. Over the last decade, they have been joined by most subscription journals, however publisher policies are often vague or ill-defined. [1] In general, most publishers that permit preprints require that:
Cancers is a peer-reviewed, open access, medical journal published by MDPI covering all fields of oncology. [1] The editor-in-chief is Samuel C. Mok (The University of Texas MD Anderson Cancer Center). The Irish Association for Cancer Research (IACR) and the Signal Transduction Society (STS) are affiliated societies.
The NIH Public Access Policy is an open access mandate, drafted in 2004 and mandated in 2008, [1] requiring that research papers describing research funded by the National Institutes of Health must be available to the public free through PubMed Central within 12 months of publication.
The ICMJE recommendations (full title, "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals") are a set of guidelines produced by the International Committee of Medical Journal Editors for standardising the ethics, preparation and formatting of manuscripts submitted to biomedical journals for publication. [1]
According to the Journal Citation Reports, the journal has a 2022 impact factor of 11.1, ranking it 12th out of 207 journals in the category "Public, Environmental & Occupational Health". [3] It is open access journal and uses the Creative Commons 3.0 IGO license (specifically CC BY 3.0 IGO). [4] [5]
In this process, articles which meet the minimum requirements for submission (such as including the necessary descriptions of funding, privacy and publication releases, ethics/institutional review board approval, statements of original work, signatures of authors, and so on,) are first looked over by a managing editor or a member of an ...
JCO Clinical Cancer Informatics [1] is an online peer-reviewed medical journal of oncology and medical informatics published by Lippincott Williams & Wilkins. The journal was established in 2017 and the editor-in-chief is Jeremy L. Warner (Brown University). Articles are published upon acceptance and after 12 months become freely available.
The journal publishes articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary cancers. The journal was previously published as Clinical Prostate Cancer through September 2005.